Cardiovascular risk assessment tools in Asia
Abstract Cardiovascular disease (CVD) is becoming the most important burden to health care systems in most part of the world, especially in Asia. Aiming at identifying high risk individuals and tailoring preventive treatment, many cardiovascular risk assessment tools have been established and most o...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-04-01
|
| Series: | The Journal of Clinical Hypertension |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jch.14336 |
| _version_ | 1797645151502336000 |
|---|---|
| author | Yuqing Zhang Huanhuan Miao Yook‐Chin Chia Peera Buranakitjaroen Saulat Siddique Jinho Shin Yuda Turana Sungha Park Kelvin Tsoi Chen‐Huan Chen Hao‐Min Cheng Yan Li Huynh Van Minh Michiaki Nagai Jennifer Nailes Jorge Sison Arieska Ann Soenarta Guru Prasad Sogunuru Apichard Sukonthasarn Jam Chin Tay Boon Wee Teo Narsingh Verma Tzung‐Dau Wang Satoshi Hoshide Kazuomi Kario Jiguang Wang |
| author_facet | Yuqing Zhang Huanhuan Miao Yook‐Chin Chia Peera Buranakitjaroen Saulat Siddique Jinho Shin Yuda Turana Sungha Park Kelvin Tsoi Chen‐Huan Chen Hao‐Min Cheng Yan Li Huynh Van Minh Michiaki Nagai Jennifer Nailes Jorge Sison Arieska Ann Soenarta Guru Prasad Sogunuru Apichard Sukonthasarn Jam Chin Tay Boon Wee Teo Narsingh Verma Tzung‐Dau Wang Satoshi Hoshide Kazuomi Kario Jiguang Wang |
| author_sort | Yuqing Zhang |
| collection | DOAJ |
| description | Abstract Cardiovascular disease (CVD) is becoming the most important burden to health care systems in most part of the world, especially in Asia. Aiming at identifying high risk individuals and tailoring preventive treatment, many cardiovascular risk assessment tools have been established and most of them were developed in Western countries. However, these cardiovascular risk assessment tools cannot be used interchangeably without recalibration because of the different risk factor profiles (ie, greater absolute burden of hypertension and lower level of total‐cholesterol in Asians and higher prevalence of metabolic disorders in South Asians) and different CVD profiles (higher ratio of stroke/coronary heart disease in Asians) between Western and Asian populations. Original risk models such as Prediction for ASCVD Risk in China (China‐PAR) and Japan Arteriosclerosis Longitudinal Study (JALS) score have been developed and well validated for specific countries, while most of countries/regions in Asia are using established models. Due to higher incidence of stroke in Asians, risk factors like hypertension should weigh more in cardiovascular risk assessment comparing with Western populations, but their actual proportions should be based on CVD profiles in specific countries/regions. The authors encourage the development of new cardiovascular risk assessment tools for Asians, if possible. Still, modifying established models with native epidemiological data of risk factor as well as CVD is acceptable in regions where health care resources are insufficient. |
| first_indexed | 2024-03-11T14:41:59Z |
| format | Article |
| id | doaj.art-3ee49b733cde40f69359564ef94a24ce |
| institution | Directory Open Access Journal |
| issn | 1524-6175 1751-7176 |
| language | English |
| last_indexed | 2024-03-11T14:41:59Z |
| publishDate | 2022-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Journal of Clinical Hypertension |
| spelling | doaj.art-3ee49b733cde40f69359564ef94a24ce2023-10-30T13:26:42ZengWileyThe Journal of Clinical Hypertension1524-61751751-71762022-04-0124436937710.1111/jch.14336Cardiovascular risk assessment tools in AsiaYuqing Zhang0Huanhuan Miao1Yook‐Chin Chia2Peera Buranakitjaroen3Saulat Siddique4Jinho Shin5Yuda Turana6Sungha Park7Kelvin Tsoi8Chen‐Huan Chen9Hao‐Min Cheng10Yan Li11Huynh Van Minh12Michiaki Nagai13Jennifer Nailes14Jorge Sison15Arieska Ann Soenarta16Guru Prasad Sogunuru17Apichard Sukonthasarn18Jam Chin Tay19Boon Wee Teo20Narsingh Verma21Tzung‐Dau Wang22Satoshi Hoshide23Kazuomi Kario24Jiguang Wang25Department of Cardiology Fu Wai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Cardiology Fu Wai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Medical Sciences School of Healthcare and Medical Sciences Sunway University Bandar Sunway Selangor Darul Ehsan MalaysiaDepartment of Medicine Division of Hypertension Faculty of Medicine Siriraj Hospital Mahidol University Bangkok ThailandPunjab Medical Center Lahore PakistanFaculty of Cardiology Service Hanyang University Medical Center Seoul KoreaSchool of Medicine and Health Sciences Atma Jaya Catholic University of Indonesia Jakarta IndonesiaDivision of Cardiology Cardiovascular Hospital, Yonsei Health System Seoul KoreaJC School of Public Health and Primary Care The Chinese University of Hong Kong Shatin Hong KongInstitute of Public Health and Community Medicine Research Center National Yang‐Ming University School of Medicine Taipei TaiwanInstitute of Public Health and Community Medicine Research Center National Yang‐Ming University School of Medicine Taipei TaiwanCentre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations Shanghai Key Lab of Hypertension Shanghai Institute of Hypertension Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai ChinaDepartment of Internal Medicine University of Medicine and Pharmacy Hue University Hue City VietnamDepartment of Internal Medicine General Medicine and Cardiology Hiroshima City Asa Hospital Hiroshima JapanDepartment of Preventive and Community Medicine and Research Institute for Health Sciences University of the East Ramon Magsaysay Memorial Medical Center Inc. Quezon City PhilippinesDepartment of Medicine Section of Cardiology Medical Center Manila Manila PhilippinesDepartment of Cardiology and Vascular Medicine Faculty of Medicine University of Indonesia‐National Cardiovascular Center Harapan Kita Jakarta IndonesiaMIOT International Hospital Chennai Tamil Nadu IndiaDepartment of Internal Medicine Cardiology Division Faculty of Medicine Chiang Mai University Chiang Mai ThailandDepartment of General Medicine Tan Tock Seng Hospital Singapore SingaporeDepartment of Medicine Division of Nephrology, Yong Loo Lin School of Medicine Singapore SingaporeDepartment of Physiology King George's Medical University Lucknow IndiaDepartment of Internal Medicine, Cardiovascular Center and Division of Cardiology National Taiwan University Hospital Taipei City TaiwanDepartment of Medicine Division of Cardiovascular Medicine Jichi Medical University School of Medicine Tochigi JapanDepartment of Medicine Division of Cardiovascular Medicine Jichi Medical University School of Medicine Tochigi JapanDepartment of Hypertension Centre for Epidemiological Studies and Clinical Trials the Shanghai Institute of Hypertension Shanghai Key Laboratory of Hypertension Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai ChinaAbstract Cardiovascular disease (CVD) is becoming the most important burden to health care systems in most part of the world, especially in Asia. Aiming at identifying high risk individuals and tailoring preventive treatment, many cardiovascular risk assessment tools have been established and most of them were developed in Western countries. However, these cardiovascular risk assessment tools cannot be used interchangeably without recalibration because of the different risk factor profiles (ie, greater absolute burden of hypertension and lower level of total‐cholesterol in Asians and higher prevalence of metabolic disorders in South Asians) and different CVD profiles (higher ratio of stroke/coronary heart disease in Asians) between Western and Asian populations. Original risk models such as Prediction for ASCVD Risk in China (China‐PAR) and Japan Arteriosclerosis Longitudinal Study (JALS) score have been developed and well validated for specific countries, while most of countries/regions in Asia are using established models. Due to higher incidence of stroke in Asians, risk factors like hypertension should weigh more in cardiovascular risk assessment comparing with Western populations, but their actual proportions should be based on CVD profiles in specific countries/regions. The authors encourage the development of new cardiovascular risk assessment tools for Asians, if possible. Still, modifying established models with native epidemiological data of risk factor as well as CVD is acceptable in regions where health care resources are insufficient.https://doi.org/10.1111/jch.14336Asian patientscardiovascular diseasehypertension—generalrisk assessment |
| spellingShingle | Yuqing Zhang Huanhuan Miao Yook‐Chin Chia Peera Buranakitjaroen Saulat Siddique Jinho Shin Yuda Turana Sungha Park Kelvin Tsoi Chen‐Huan Chen Hao‐Min Cheng Yan Li Huynh Van Minh Michiaki Nagai Jennifer Nailes Jorge Sison Arieska Ann Soenarta Guru Prasad Sogunuru Apichard Sukonthasarn Jam Chin Tay Boon Wee Teo Narsingh Verma Tzung‐Dau Wang Satoshi Hoshide Kazuomi Kario Jiguang Wang Cardiovascular risk assessment tools in Asia The Journal of Clinical Hypertension Asian patients cardiovascular disease hypertension—general risk assessment |
| title | Cardiovascular risk assessment tools in Asia |
| title_full | Cardiovascular risk assessment tools in Asia |
| title_fullStr | Cardiovascular risk assessment tools in Asia |
| title_full_unstemmed | Cardiovascular risk assessment tools in Asia |
| title_short | Cardiovascular risk assessment tools in Asia |
| title_sort | cardiovascular risk assessment tools in asia |
| topic | Asian patients cardiovascular disease hypertension—general risk assessment |
| url | https://doi.org/10.1111/jch.14336 |
| work_keys_str_mv | AT yuqingzhang cardiovascularriskassessmenttoolsinasia AT huanhuanmiao cardiovascularriskassessmenttoolsinasia AT yookchinchia cardiovascularriskassessmenttoolsinasia AT peeraburanakitjaroen cardiovascularriskassessmenttoolsinasia AT saulatsiddique cardiovascularriskassessmenttoolsinasia AT jinhoshin cardiovascularriskassessmenttoolsinasia AT yudaturana cardiovascularriskassessmenttoolsinasia AT sunghapark cardiovascularriskassessmenttoolsinasia AT kelvintsoi cardiovascularriskassessmenttoolsinasia AT chenhuanchen cardiovascularriskassessmenttoolsinasia AT haomincheng cardiovascularriskassessmenttoolsinasia AT yanli cardiovascularriskassessmenttoolsinasia AT huynhvanminh cardiovascularriskassessmenttoolsinasia AT michiakinagai cardiovascularriskassessmenttoolsinasia AT jennifernailes cardiovascularriskassessmenttoolsinasia AT jorgesison cardiovascularriskassessmenttoolsinasia AT arieskaannsoenarta cardiovascularriskassessmenttoolsinasia AT guruprasadsogunuru cardiovascularriskassessmenttoolsinasia AT apichardsukonthasarn cardiovascularriskassessmenttoolsinasia AT jamchintay cardiovascularriskassessmenttoolsinasia AT boonweeteo cardiovascularriskassessmenttoolsinasia AT narsinghverma cardiovascularriskassessmenttoolsinasia AT tzungdauwang cardiovascularriskassessmenttoolsinasia AT satoshihoshide cardiovascularriskassessmenttoolsinasia AT kazuomikario cardiovascularriskassessmenttoolsinasia AT jiguangwang cardiovascularriskassessmenttoolsinasia |